Midbrain binding of [123I]nor-β-CIT in atypical depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 7, 2006, Pages 1251-1255

  Lehto, Soili ^a   Tolmunen, Tommi ^a   Joensuu, Mikko ^a   Saarinen, Pirjo Irmeli ^a   Vanninen, Ritva ^a   Ahola, Pasi ^a   Tiihonen, Jari ^b   Kuikka, Jyrki ^a   Lehtonen, Johannes ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Atypical depression; DAT; Depression; Melancholia; Serotonin transporter; SERT; SPECT

Indexed keywords

2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)TROPANE I 123; DOPAMINE TRANSPORTER; SEROTONIN TRANSPORTER; TRACER; UNCLASSIFIED DRUG; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE; DRUG DERIVATIVE; IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; ATYPICAL DEPRESSION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HAMILTON SCALE; HUMAN; MALE; MELANCHOLIA; MESENCEPHALON; SCORING SYSTEM; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANALYSIS OF VARIANCE; DEPRESSION; EVALUATION; METABOLISM; PSYCHOLOGICAL RATING SCALE; REPRODUCIBILITY; SCINTISCANNING; STATISTICS;

ADULT; ANALYSIS OF VARIANCE; COCAINE; DEPRESSION; FEMALE; HUMANS; IODINE ISOTOPES; MALE; MESENCEPHALON; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33747075107     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.03.019     Document Type: Article

References (37)

1. Acton P.D., Kushner S.A., Kung M.P., Mozley P.C., Plossl K., and Kung H.F. Simplified reference region model for the kinetic analysis of [99 mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography. Eur J Nucl Med 26 (1990) 518-526
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Press, Washington (DC)
3. Angst J., and Merikangas K.R. Multidimensional criteria for the diagnosis of depression. J Affect Disord 62 1-2 (2001) 7-15
4. Asnis G.M., McGinn L.K., and Sanderson W.C. Atypical depression: clinical aspects and noradrenergic function. Am J Psychiatry 152 1 (1995) 31-36
5. Benazzi F. Can only reserved vegetative symptoms define atypical depression. Eur Arch Psychiatry Clin Neurosci 252 (2002) 288-293
6. Benazzi F. The symptoms of atypical depression. Can J Psychiatry 48 (2003) 350-351
7. Benazzi F. Depressive mixed state: dimensional versus categorical definitions. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 129-134
8. Eggers B., Hermann W., Barthel H., Sabri O., Wagner A., and Hesse S. The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson's disease. J Neurol 250 (2003) 576-580
9. Fountoulakis K.N., Iacovides A., Fotiou F., Nimatoudis J., Bascialla F., Ioanniou Ch., et al. Neurobiological and psychological correlates of suicidal attempts and thoughts of death in patients with major depression. Neuropsychobiol 49 1 (2004) 42-52
10. Fountoulakis K.N., Kaprinis St.G., Kaprinis G., Iacovides A., and Fotiou F. Biological markers and psychophysiological methods as long-term response predictors to fluoxetine treatment. J Affect Disord 80 2-3 (2004) 291-292
11. Fountoulakis K.N., Iacovides A., Gerasimou G., Fotiou F., Ioannidou C., Bascialla F., et al. The relationship of regional cerebral blood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 537-546
12. Gold P.W., and Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 7 (2002) 254-275
13. Gold P.W., Licinio J., Wong M.L., and Chrousos G.P. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and the mechanism of action of antidepressant drugs. Ann NY Acad Sci 771 (1995) 716-729
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
15. Hiltunen J., Åkerman K., Kuikka J., Bergström K., Halldin C., Nikula T., et al. Iodine-123 labeled nor-β-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography. Eur J Nucl Med 25 (1998) 19-23
16. Kuikka J.T., Tenhunen-Eskelinen M., Jurvelin J., and Kiiliäinen H. Physical performance of the Siemens MultiSPECT3 gamma camera. Nucl Med Commun 23 (1993) 798-803
17. Laasonen-Balk T., Viinamäki H., Kuikka J.T., Husso-Saastamoinen M., Lehtonen J., and Tiihonen J. Serotonin transporter density and recovery from depression: a six-month follow up study. Eur Arch Neurosci 254 (2004) 152-155
18. Levitan R.D., Lesage A., Parikh S.V., Goering P., and Kennedy S.H. Reversed neurovegetative symptoms of depression: a community study of Ontario. Am J Psychiatry 154 (1997) 934-940
19. Levitan R.D., Vaccarino F.J., Franco J., Brown G.M., and Kennedy S.H. Low-dose dexamethasone challenge in women with atypical major depression: pilot study. J Psychiatr Neurosci 27 (2002) 47-51
20. Liebowitz M.R., Quitkin F.M., Stewart J.W., McGrath P.J., Harrison W., Rabkin J.G., et al. Psychopharmacologic validation of atypical depression. J Clin Psychiatry 45 (1984) 22-25
21. Malison R.T., Price LH., Berman R., van Dyck C.H., Pelton G.H., Carpenter L., et al. Reduced brain serotonin transporter availability in major depression as measured by (4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry 44 (1998) 1090-1098
22. Matza L.S., Revicki D.A., Davidson J.R., and Stewart J.W. Depression with atypical features in the National Comorbidity Survey. Arch Gen Psychiatry 60 (2003) 817-826
23. McGrath P.J., Stewart J.W., Quitkin F.M., Wager S., Jenkins S.W., Archibald D.G., et al. Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement. J Clin Psychopharmacol 14 (1994) 347-352
24. Parker G., Roussos J., Hadzi-Pavlovic D., Wilhelm K., Mitchell P., and Austin M.-P. Plumbing the depths: some problems in quantifying depression severity. J Affect Disord 42 (1997) 49-58
25. Parker G., Roy K., Mitchell P., Wilhelm K., Malhi G., and Hadzi-Pavlovic D. Atypical depression: a reappraisal. Am J Psychiatry 159 (2002) 1470-1479
26. Posternak M.A. Biological markers of atypical depression. Harv Rev Psychiatr 11 (2003) 1-7
27. Quitkin F.M., Stewart J.W., McGrath P.J., Liebowitz M.R., Harrison W.M., Tricamo E., et al. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 145 (1988) 306-311
28. Quitkin F.M., McGrath P.J., Stewart J.W., Harrison W.M., Tricamo E., Wager S.G., et al. Atypical depression, panic attacks, and responds to imipramine and phenelzine: a replication. Arch Gen Psychiatry 47 (1990) 935-941
29. Saarinen P.I., Joensuu M., Tolmunen T., Ahola P., Kuikka J., and Lehtonen J. Outcome of psychodynamic psychotherapy: activation of the dream screen and change in the serotonin transporter density. Am J Psychother 59 (2005) 61-73
30. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.-T., Appel M., and Rothman D.L. Subtype-specific alterations in gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61 (2004) 705-713
31. Staley J.K., Malison R.T., and Innis R.B. Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression. Biol Psychiatry 44 (1998) 534-549
32. Stewart J.W., McGrath P., Rabkin J., and Quitkin F.M. Atypical depression: a valid clinical entity. Psychiatr Clin North Am 16 3 (1993) 479-495
33. Talairach J., and Tournoux P. Referentially oriented cerebral MRI anatomy (1993), Thieme Medical Publishers, New York
34. Tolmunen T., Joensuu M., Saarinen P., Mussalo H., Ahola P., Kuikka J., et al. Elevated serotonin transporter density in mixed mania: a case-control study. BMC Psychiatry 4 (2004) 27
35. Viinamäki H., Kuikka J., Tiihonen J., and Lehtonen J. Change in monoamine transporter density related to clinical recovery: a case-control study. Nord J Psychiatry 52 (1998) 39-44
36. 123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry 47 (2000) 482-489
37. Williams J.B., Link M.J., Rosenthal N.E., and Terman M. Structured interview guide for the Hamilton Depression Rating Scale. Seasonal affective disorders version (1988), New York Psychiatric Institute, New York